Skip to Main Content

Paper Details

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.
Leuk Res
134
2007
AML, GO, Gemtuzumab ozogamicin, SOS, VOD, ascites, hepatic veno-occlusive disease, hyperbilirubinemia, painful hepatomegaly, participants, patients, relapsed acute myeloid leukemia, sinusoidal obstructive syndrome, thioguanine
Author NameAffiliation
June M McKoyFeinberg School of Medicine, Northwestern University
  • 1 - 1

Datasets

Release 1.2